Innovation with a non-profit heart
Medixcel Innov is the group’s non-profit arm, where the story moves from supplying medicine to creating it. Three flagship projects take Saudi healthcare up the value chain: training on the world’s discoveries, trialling new medicines here at home, and building the intelligent tools that guide everyday care.
The non-profit innovation arm of the Medixcel group.
- AI tools for doctors
- Precision medicine and research
- Hands-on clinical training
Phase I trials & early drug discovery
Adopting first-in-human, Phase I drug trials in the Kingdom, backed by pre-clinical discovery programmes that plant the seeds of a homegrown Saudi drug pipeline. In partnership with Evideep, a Swiss clinical research specialist, every study is managed end to end: protocol design, regulatory files, data capture and monitoring, all to international standards.
AI tools for doctors
AI-powered clinical decision support that puts world-class diagnostic intelligence in the hands of Saudi clinicians, turning patient data into personalised treatment choices at the bedside.
Bioskill Lab
A hands-on surgical simulation and cadaveric training facility, giving Saudi surgeons the rare, high-end skills practice that world-class care demands.
Hands-on training for clinical readiness
A training hub for healthcare professionals across specialties, accelerating clinical readiness through realistic practice.
- High-fidelity surgical simulators and advanced imaging systems
- Cadaveric training for high-realism procedural practice
- International workshops and certification programmes
- Alignment with Vision 2030 medical education objectives
AI tools for doctors
Clinical decision support, inventory intelligence and AI-assisted discovery: practical tools measured by their effect at the bedside.
Precision medicine & research
Data-driven, individually tailored treatment pathways, built with Phenome’s multi-omics laboratories and Trustlife’s AI discovery platform.
Evideep
Clinical research data platform · Basel, Switzerland
Evideep AG is a Swiss data and technology company serving clinical research: AI-assisted patient matching for clinical trials, real-world data and site operations, with natural-language processing applied to clinical records. It is led by its CEO, Dr. Barış Erdoğan.
Every study managed end to end
With Evideep, Medixcel Innov runs Phase I trials and discovery programmes in the Kingdom to international standards.
Measured by patients, not margin
Medixcel Innov is organised as a non-profit so that each project is judged by one standard: whether it directly helps patients and strengthens the health system. The group’s commercial strength funds the work; the clinic decides whether it succeeded.